Skip to content
Trial Eligibility
Menu

Multiple Sclerosis Clinical Trials near Boston, MA

23 studies for Multiple Sclerosis are recruiting at 34 sites within 50 miles of Boston, Massachusetts, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near Boston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Multiple Sclerosis studies enrolling near Boston

Showing 23 studies, nearest first.
  1. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    NCT05877963

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (Boston, MA); TG Therapeutics Investigational Trial Site (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  2. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    NCT06433752

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (Boston, MA); TG Therapeutics Investigational Trial Site (Burlington, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Massachusetts General Hospital Cancer Center (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. Efgartigimod for the Treatment of Acute Optic Neuritis

    NCT06453694

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Massachusetts Eye and Ear Infirmary (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    NCT07002034

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Dana Farber Cancer Institute (Boston, MA); University of Massachusetts Chan Medical Center (Worcester, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

    NCT02649985

    • Phase 1/2
    • Ages 18 to 85 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Brigham MS Center, 60 Fenwood Road (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Molecular Imaging of NET Using [C-11]MRB-PET in MS

    NCT03207464

    • Phase 1/2
    • Ages 18 to 60 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Brigham MS Center, 60 Fenwood Road (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

    NCT04603196

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Beth Israel Deaconess Medical Center (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Assessment of Synaptic Density in MS

    NCT04634994

    • Early Phase 1
    • Ages 18 to 60 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Brigham and Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects

    NCT04699747

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis

    NCT06136728

    • Phase 3
    • Ages 25 to 75 years
    • Sex: All

    Nearest site: MGH Institute of Health Professions (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

    NCT06554340

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: UMass Boston (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

    NCT06890923

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Brigham and Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Care in Multiple Sclerosis (MS)

    NCT07011914

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Glucose Consumption in MS Using [F-18]FDG-PET

    NCT07087106

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Brigham & Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis

    NCT02486562

    • Observational
    • Ages Any age
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Accelerated Cure Project (Waltham, MA)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    NCT06846281

    • Phase 3
    • Ages 40 to 70 years
    • Sex: All

    Nearest sites: Lahey Hospital and Medical Center (Burlington, MA); Neurology Center of New England PC (Foxborough, MA)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

    NCT07225504

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Elliot Lewis MS Center (Wellesley, MA); Neuro Institute of New England P C (Foxborough, MA)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

    NCT06681623

    • Observational
    • Ages 55 to 80 years
    • Sex: All

    Nearest site: Neurology Center of New England P.C. (Foxborough, MA)

    Distance to nearest recruiting site
    ~22 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

    NCT06782490

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Neurology Center of New England (Foxborough, MA)

    Distance to nearest recruiting site
    ~22 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    NCT07325292

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Neurology Center of New England- Site Number : 8400164 (Foxborough, MA)

    Distance to nearest recruiting site
    ~22 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    NCT04047628

    • Phase 3
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: University of Massachusetts Memorial Medical Center (Worcester, MA)

    Distance to nearest recruiting site
    ~39 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    NCT07299019

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: University of Massachusetts Memorial Medical Center (Worcester, MA)

    Distance to nearest recruiting site
    ~39 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Multiple Sclerosis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.